| Erectile dysfunction FA Yafi, L Jenkins, M Albersen, G Corona, AM Isidori, S Goldfarb, ... Nature reviews Disease primers 2 (1), 1-20, 2016 | 744 | 2016 |
| Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes E Basch, X Jia, G Heller, A Barz, L Sit, M Fruscione, M Appawu, A Iasonos, ... JNCI: Journal of the National Cancer Institute 101 (23), 1624-1632, 2009 | 643 | 2009 |
| Interventions to address sexual problems in people with cancer: American Society of Clinical Oncology clinical practice guideline adaptation summary J Carter, C Lacchetti, JH Rowland Journal of oncology practice 14 (3), 173-179, 2018 | 302 | 2018 |
| Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The … SS Faubion, LC Larkin, CA Stuenkel, GA Bachmann, LA Chism, R Kagan, ... Menopause 25 (6), 596-608, 2018 | 189 | 2018 |
| Detection of HER2-positive metastases in patients with HER2-negative primary breast cancer using 89Zr-trastuzumab PET/CT GA Ulaner, DM Hyman, DS Ross, A Corben, S Chandarlapaty, S Goldfarb, ... Journal of Nuclear Medicine 57 (10), 1523-1528, 2016 | 183 | 2016 |
| Sexual health needs and educational intervention preferences for women with cancer C Stabile, S Goldfarb, RE Baser, DJ Goldfrank, NR Abu-Rustum, ... Breast cancer research and treatment 165, 77-84, 2017 | 139 | 2017 |
| Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient’s perspective A Hurria, S Goldfarb, C Rosen, J Holland, E Zuckerman, MS Lachs, ... Breast cancer research and treatment 98, 343-348, 2006 | 120 | 2006 |
| A phase II open-label study of ganetespib, a novel heat shock protein 90 inhibitor for patients with metastatic breast cancer K Jhaveri, S Chandarlapaty, D Lake, T Gilewski, M Robson, S Goldfarb, ... Clinical breast cancer 14 (3), 154-160, 2014 | 110 | 2014 |
| How to ask and what to do: a guide for clinical inquiry and intervention regarding female sexual health after cancer SL Bober, JB Reese, L Barbera, A Bradford, KM Carpenter, S Goldfarb, ... Current opinion in supportive and palliative care 10 (1), 44-54, 2016 | 106 | 2016 |
| Phase II study of paclitaxel given once per week along with Trastuzumab and Pertuzumab in patients with human epidermal growth factor receptor 2–positive metastatic breast Cancer C Dang, N Iyengar, F Datko, G D'Andrea, M Theodoulou, M Dickler, ... Journal of Clinical Oncology 33 (5), 442, 2015 | 106 | 2015 |
| Cancer and fertility program improves patient satisfaction with information received JF Kelvin, B Thom, C Benedict, J Carter, S Corcoran, MN Dickler, ... Journal of Clinical Oncology 34 (15), 1780, 2016 | 98 | 2016 |
| Effect of aromatase inhibitors on background parenchymal enhancement and amount of fibroglandular tissue at breast MR imaging V King, SB Goldfarb, JD Brooks, JS Sung, BF Nulsen, JE Jozefara, ... Radiology 264 (3), 670-678, 2012 | 85 | 2012 |
| Endocrine therapy–induced alopecia in patients with breast cancer A Freites-Martinez, J Shapiro, D Chan, M Fornier, S Modi, D Gajria, ... JAMA dermatology 154 (6), 670-675, 2018 | 84 | 2018 |
| Hair disorders in patients with cancer A Freites-Martinez, J Shapiro, S Goldfarb, J Nangia, JJ Jimenez, R Paus, ... Journal of the American Academy of Dermatology 80 (5), 1179-1196, 2019 | 80 | 2019 |
| Hair disorders in cancer survivors A Freites-Martinez, J Shapiro, C van den Hurk, S Goldfarb, JJ Jimenez, ... Journal of the American Academy of Dermatology 80 (5), 1199-1213, 2019 | 78 | 2019 |
| Sexual and reproductive health in cancer survivors S Goldfarb, J Mulhall, C Nelson, J Kelvin, M Dickler, J Carter Seminars in oncology 40 (6), 726-744, 2013 | 70 | 2013 |
| Vaginal and sexual health treatment strategies within a female sexual medicine program for cancer patients and survivors J Carter, C Stabile, B Seidel, RE Baser, S Goldfarb, DJ Goldfrank Journal of Cancer Survivorship 11, 274-283, 2017 | 67 | 2017 |
| Sexual functioning among endometrial cancer patients treated with adjuvant high-dose-rate intra-vaginal radiation therapy S Damast, KM Alektiar, S Goldfarb, A Eaton, S Patil, J Mosenkis, ... International Journal of Radiation Oncology* Biology* Physics 84 (2), e187-e193, 2012 | 57 | 2012 |
| The risk of nail changes with taxane chemotherapy: a systematic review of the literature and meta‐analysis K Capriotti, JA Capriotti, S Lessin, S Wu, S Goldfarb, VR Belum, ... British Journal of Dermatology 173 (3), 842-845, 2015 | 55 | 2015 |
| Assessment of quality of life and treatment outcomes of patients with persistent postchemotherapy alopecia A Freites-Martinez, D Chan, V Sibaud, J Shapiro, G Fabbrocini, A Tosti, ... JAMA dermatology 155 (6), 724-728, 2019 | 54 | 2019 |
